Comment:

S Fruehauf

Long awaited: CD34+ determination in steady-state hematopoiesis by real-time polymerase chain reaction
Haematologica 2005 90: 865A.  

C Thiede

MLL-PTD as a marker for minimal residual disease studies: quantification counts
Haematologica 2005 90: 865B.  

S Knuutila

A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of leukemias
Haematologica 2005 90: 866.  

D Campana

ZAP-70 tyrosine kinase is constitutively expressed and phosphorylated in B-lineage acute lymphoblastic leukemia cells
Haematologica 2005 90: 867.  

A Rawstron

Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma
Haematologica 2005 90: 867B.  

B Olsson

Type 1 and type 2 T cells profile in idiopathic thrombocytopenic purpura
Haematologica 2005 90: 868.  

C Mannhalter

The Malmo International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A
Haematologica 2005 90: 869A.  

N Kroger

Rabbit-IgG levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation
Haematologica 2005 90: 869B.  

M Remberger

Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
Haematologica 2005 90: 870.  

M Cazzola, R Skoda

Gain of function, loss of control - a molecular basis for chronic myeloproliferative disorders
Haematologica 2005 90: 871-874. [PDF]  

Journal Article:

E Oppliger Leibundgut, C Brunold, D Marti, MP Horn, C Seiler, V Schroeder, JP Schmid, A Tobler, C Zwicky

Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction
Haematologica 2005 90: 875-880. [Abstract] [PDF]  

M Weisser, W Kern, C Schoch, W Hiddemann, T Haferlach, S Schnittger

Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy
Haematologica 2005 90: 881-889. [Abstract] [PDF]  

C De Pitta, L Tombolan, M Campo Dell'Orto, B Accordi, G te Kronnie, C Romualdi, N Vitulo, G Basso, G Lanfranchi

A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia
Haematologica 2005 90: 890-898. [Abstract] [PDF]  

N Guillaume, C Alleaume, D Munfus, JC Capiod, G Touati, B Pautard, B Desablens, JJ Lefrere, F Gouilleux, K Lassoued, V Gouilleux-Gruart

ZAP-70 tyrosine kinase is constitutively expressed and phosphorylated in B-lineage acute lymphoblastic leukemia cells
Haematologica 2005 90: 899-905. [Abstract] [PDF]  

D Gonzalez, M Gonzalez, A Balanzategui, ME Sarasquete, R Lopez-Perez, MC Chillon, R Garcia-Sanz, JF San Miguel

Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma
Haematologica 2005 90: 906-913. [Abstract] [PDF]  

T Wang, H Zhao, H Ren, J Guo, M Xu, R Yang, ZC Han

Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura
Haematologica 2005 90: 914-923. [Abstract] [PDF]  

J Astermark, J Oldenburg, M Escobar, GC White, 2nd, E Berntorp, Malmo International Brother Study study group

The Malmo International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A
Haematologica 2005 90: 924-931. [Abstract] [PDF]  

M Remberger, B Sundberg

Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation
Haematologica 2005 90: 931-938. [Abstract] [PDF]  

KH Lee, SJ Choi, JH Lee, JS Lee, WK Kim, KB Lee, SK Sohn, JG Kim, DH Kim, M Seol, YS Lee, JH Lee

Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
Haematologica 2005 90: 939-948. [Abstract] [PDF]  

Y Chalandon, J Schwaller

Targeting mutated protein tyrosine kinases and their signaling pathways in hematologic malignancies
Haematologica 2005 90: 949-968. [Abstract] [PDF]  

B Hertenstein, L Hambach, A Bacigalupo, N Schmitz, S McCann, S Slavin, A Gratwohl, A Ferrant, A Elmaagacli, R Schwertfeger, A Locasciulli, A Zander, M Bornhauser, D Niederwieser, T Ruutu, Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation

Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT)
Haematologica 2005 90: 969-975. [Abstract] [PDF]  

Letter:

R Ciancia, V Martinelli, E Cosentini, M Picardi, F Petruzziello, E Matano, B Rotoli

High number of circulating CD34+ cells in patients with myelophthisis
Haematologica 2005 90: 976-977. [Abstract] [PDF]  

RN Costa, N Conran, DM Albuquerque, PH Soares, ST Saad, FF Costa

Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia
Haematologica 2005 90: 977-979. [Abstract] [PDF]  

H Matsuoka, T Murayama, T Koizumi, R Nishimura, R Kawaguchi, T Nakagawa

Establishment of a human myeloid cell line with trisomy 8 derived from overt leukemia following myelodysplastic syndrome
Haematologica 2005 90: 981-982. [Abstract] [PDF]  

MT Voso, F D'Alo', D Gumiero, F Guidi, S Hohaus, G Leone

The CYP1A1*2a allele is an independent prognostic factor for acute myeloid leukemia
Haematologica 2005 90: 982-984. [Abstract] [PDF]  

M Hutchings Hoffmann, T Wirenfeldt Klausen, H Hasle, K Schmiegelow, K Brondum-Nielsen, HE Johnsen

Multiplex reverse transcription polymerase chain reaction screening in acute myeloid leukemia detects cytogenetically unrevealed abnormalities of prognostic significance
Haematologica 2005 90: 984-986. [Abstract] [PDF]  

E Raffoux, P Chaibi, H Dombret, L Degos

Valproic acid and all-trans retinoic acid for the treatment of elderly patients with acute myeloid leukemia
Haematologica 2005 90: 986-988. [Abstract] [PDF]  

RH Gunby, CJ Tartari, F Porchia, A Donella-Deana, L Scapozza, C Gambacorti-Passerini

An enzyme-linked immunosorbent assay to screen for inhibitors of the oncogenic anaplastic lymphoma kinase
Haematologica 2005 90: 988-990. [Abstract] [PDF]  

A Oriol, JM Ribera, S Brunet, E del Potro, E Abella, J Esteve

Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study
Haematologica 2005 90: 990-992. [Abstract] [PDF]  

MA Catherwood, JP Wall, TC Morris, HD Alexander

Detection of tumor-derived antigen receptor DNA by polymerase chain reaction in the serum of patients with B-cell chronic lymphocytic leukemia
Haematologica 2005 90: 992-994. [Abstract] [PDF]  

T Robak, JZ Blonski, M Kasznicki, J Gora-Tybor, A Dmoszynska, A Skotnicki

The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil
Haematologica 2005 90: 994-996. [Abstract] [PDF]  

M Acquila, M Pasino, T Lanza, AC Molinari, C Rosano, MP Bicocchi

Exon skipping partially restores factor VIII coagulant activity in patients with mild hemophilia A with exon 13 duplication
Haematologica 2005 90: 997-999. [Abstract] [PDF]  

A Hori, M Kami, M Ohnishi, N Murashige, R Kojima, Y Takaue

Feasibility of early tapering of cyclosporine following reduced-intensity stem cell transplantation for advanced hematologic or solid malignancies
Haematologica 2005 90: 1001-1003. [Abstract] [PDF]  

M Shapira, SN Adler, H Jacob, IB Resnick, S Slavin, R Or

New insights into the pathophysiology of gastrointestinal graft-versus-host disease using capsule endoscopy
Haematologica 2005 90: 1003-1004. [Abstract] [PDF]  

Case Reports:

S Merante, E Orlandi, P Bernasconi, S Calatroni, M Boni, M Lazzarino

Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuation
Haematologica 2005 90: 979-981. [Abstract] [PDF]  

O Takamiya, S Machida, M Yamamoto

Factor XI deficiency with a novel homozygous mutation Trp599Arg near the C-terminal region
Haematologica 2005 90: 999-1001. [Abstract] [PDF]  

Clinical Trial:

KL Wu, W van Wieringen, E Vellenga, S Zweegman, HM Lokhorst, P Sonneveld

Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice
Haematologica 2005 90: 996-997. [Abstract] [PDF]  

GJ Timmers, DG van Vuurden, EL Swart, AM Simoons-Smit, PC Huijgens

Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies
Haematologica 2005 90: 1005-1006. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.